By Carson Lorts, CPA, Senior Manager at Blue & Co. Qualified Opportunity Zones have now been around for nearly 10 years after their creation under the Tax Cuts & Jobs […]
Read More
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
Read More
In early April 2026, a notice was sent from CMS to each MAC regarding the April 30th, 2026, release of the final FY 2027 wage index data PUFs. May 29th, […]
Read More
It’s March Madness, and we are not talking about basketball. The clock is ticking on the FY 2027 Medicare Wage Index; this process moves quickly, and missing a deadline can […]
Read More
Covered entities have until Friday, March 27th to submit comments to FSSA ahead of proposed changes to eliminate 340B Program savings for Medicaid patients. The window is quickly closing for […]
Read More
When a teaching hospital closes, there are several factors the hospital must consider. While there are many financial factors the hospital must figure out, including how to pay outstanding debts […]
Read More
They sit in your computer’s hard drive, or perhaps even in an old file cabinet in the corner. They can create a lot of unnecessary work, force you to devote […]
Read More
Effective July 1, 2025, the state has expanded oversight of the 340B Program, requiring all hospital covered entities with a service address in Indiana to submit detailed annual reports to […]
Read More
With the exception of the COVID-19 pandemic timeframe, HRSA has long required hospital child sites to be reflected on a Medicare Cost Report prior to registration. A federal court now […]
Read More
According to Medscape’s 2025 Physician Compensation Report, four specialties now average over $500,000 annually, with orthopedic surgery topping the list at $543,000. The report, based on responses from over 7,300 […]
Read More
By Jonah Gjertson, Senior Consultant at Blue & Co. Preparing to sell your business is a complicated, emotional, and logistically challenging decision with material financial implications. There are many decisions […]
For hospitals that would like to withdraw an approved Geographic Reclassification, the publishing of the FY 2027 proposed rule starts the 45-day window for withdrawing approved Medicare Geographic Classification Review […]
The 340B Drug Pricing Program is more than a pharmacy benefit; it is a lifeline for vulnerable communities and patients. However, as federal scrutiny and manufacturer challenges intensify, maintaining program […]
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.
